ArdorComm Media Group

Monday, July 7, 2025 3:40 AM

Health & Wellness Community

Indian citizens and students are now eligible for a booster shot, according to the health minister

People travelling overseas can now get Covid booster shots if they need them, according to the Center. This follows NTAGI’s recommendation to reduce the time between the second and third shots for persons travelling abroad. “Indian citizens & students travelling overseas can now take the precaution dose as required by the guidelines of the destination country.” Health Minister Mansukh Mandaviya wrote on Twitter. The National Technical Advisory Group on Immunization (NTAGI) said on Wednesday that those who want to go overseas can shorten the nine-month gap between the second and booster doses of the covid-19 vaccine, as required by the government. The recommendation was later forwarded to the Union Health ministry. Several requests for the precaution dose of Covid vaccine have been received by the Centre in recent months from people who need to travel abroad for work, business, admission to foreign educational institutes, participation in sports events, and bilateral and multilateral meetings as part of India’s official delegation. “The issue was discussed in a meeting of NTAGI held last week after which it recommended that those who need to travel overseas can take the booster shot, before the stipulated nine-month waiting period, as per the booster guidelines of the country they are travelling to,” a source told PTI. Meanwhile, NTAGI is meeting again this week to analyse data for covid-19 immunisation of children aged 5 to 12 years old and to finalise vaccination protocols. The results of the last two meetings were inconclusive, with NTAGI experts remaining sceptical of the paediatric data available for vaccination. Source: Mint

Indian citizens and students are now eligible for a booster shot, according to the health minister Read More »

Medikabazaar has completed a successful test of drone delivery of medical supplies

New Delhi: Medikabazaar is paving the way for the next big thing in healthcare supply chain management by using drones to transport medical supplies to B2B space. In accordance with Medikabazaar’s objective of revolutionising healthcare, the company has started a trial drone project with Redwing Labs to transport medical supplies and evaluate the potential of drones as a last-mile delivery option, particularly in emergency situations. In Bengaluru, the first scheduled test drone delivery was completed successfully. The trial in Bengaluru aimed to deliver medical supplies by drone. The drone in use has a maximum range of 35 kilometres and can transport payloads weighing one to ten kilogrammes. The initiative seeks to provide medical supplies to many places in rural, urban, and semi-urban areas, including those where traditional forms of distribution take much longer due to difficult terrain. Medikabazaar’s pilot initiative seeks to have a large-scale influence and dedication to revolutionise healthcare by making it available to even the most remote locations for emergency situations. Vivek Tiwari, CEO & Founder of Medikabazaar emphasised on the initiative saying, “The ‘Pilot Drone Project’ using drones is in line with our commitment to transform healthcare by way of technology. Faster delivery of critical and emergency medical supplies, vaccines, lifesaving drugs, devices, and equipment can be a great contributor to saving lives. This project is one of the first such programmes in the country where drones are used to deliver medical supplies to hospital centres. The vision is to ensure easy healthcare accessibility throughout the nation, from the most populous to the most remote areas of India in the near future.” In addition, the effort aims to reduce the load on frontline health professionals and supply chain management. Drones that transport medical supplies straight to hospitals save time and assist healthcare staff in providing better patient care. Source: Economic Times

Medikabazaar has completed a successful test of drone delivery of medical supplies Read More »

Eris Lifesciences acquires Oaknet Healthcare for 650cr

Eris Lifesciences Ltd, a branded formulations manufacturer, acquired a 100 percent stake in Mumbai-based Oaknet Healthcare Private Ltd for Rs 650 crore on Tuesday. Oaknet Healthcare specialises in dermatology formulations. Oaknet Healthcare will become a wholly-owned subsidiary of Eris as a result of the acquisition, which will be executed through a share purchase agreement. Eris’ foray into the dermatological segment will be aided by the acquisition, which will allow the company to expand its portfolio, expand its market reach and penetration, and boost its segment ranking. Oaknet Healthcare offers products in dermatology, gynaecology, pain management, nutrition, cardiology, and diabetes, among other segments. “As Oaknet Healthcare becomes part of the Eris Group, it provides us with a robust growth platform in the areas of dermatology and cosmetology,” said Amit Bakshi, CMD, Eris Lifesciences. We are confident that the transaction will create long-term value for our shareholders, in line with the Strides and Zomelis acquisitions.” Eris now has a portfolio of leading dermatological and women’s health brands from Oaknet Healthcare. Oaknet specialises in the production of skincare goods such as moisturisers and anti-fungal creams, among others. “The acquisition of Oaknet brings marquee brands like Cosvate and Cosmelite into the Eris portfolio,” said Krishnakumar V, executive director and chief operating officer of Eris Lifesciences Ltd. We expect to bring to bear multiple value creation levers including in-house manufacturing, new product launches, expansion of field force productivity and enhancement of operational efficiency.” Source: TNN

Eris Lifesciences acquires Oaknet Healthcare for 650cr Read More »

India’s Covid positivity rate past 1 per cent again after two months

According to data published on Monday by the Union Health Ministry, India’s Covid case positivity rate surpassed 1% for the first time in over two months, as the country saw a single-day increase of 3,157 infections and 26 fatalities. According to the data, the increase boosted the country’s entire Covid tally to 4,30,82,345 cases and 5,23,869 deaths. The number of active cases increased by 408 in a 24-hour period to 19,500, according to figures updated at 8 a.m. After a little more than two months, the daily positivity increased to 1.07 percent, according to the ministry. On February 27, it was at 1.11 percent. According to the health ministry, the weekly positivity rate was 0.70 percent. The percentage of all coronavirus tests that yield a positive result is referred to as the positivity rate. A greater positive rate indicates that the virus is spreading more quickly. With the additional 26 fatalities reported, the death toll has now risen to 5,23,869, with 21 of them from Kerala alone. Active cases account for only 0.05 percent of all infections. The COVID-19 recovery rate in the country was 98.74 percent, according to the health ministry. The number of persons who have recovered from the disease has risen to 4,25,38,976, with a 1.22 percent case fatality rate. The total number of doses given out in the country as part of the nationwide COVID-19 vaccination effort has surpassed 189.23 crore. On August 7, 2020, India’s COVID-19 tally surpassed 20 lakh, followed by 30 lakh on August 23, 40 lakh on September 5, and 50 lakh on September 16. On December 19, it exceeded the one-crore mark. On May 4, India passed the two-crore mark, and on June 23, it passed the three-crore mark. Kerala has 21 new fatalities, Odisha has two, while Karnataka, Uttar Pradesh, and West Bengal each have one. So far, the country has reported 5,23,869 deaths, including 1,47,843 in Maharashtra, 69,068 in Kerala, 40,102 in Karnataka, 38,025 in Tamil Nadu, 26,175 in Delhi, 23,508 in Uttar Pradesh, and 21,202 in West Bengal. More than 70% of deaths, according to the health ministry, were caused by comorbidities. “Our figures are being reconciled with (those of) the Indian Council of Medical Research,” the ministry wrote on its website, adding that the state-by-state distribution of figures is still being verified and reconciled. Source: PTI

India’s Covid positivity rate past 1 per cent again after two months Read More »

Teleconsultation will help rural areas boost their healthcare

Jaipur: The health department has decided to use teleconsultation to boost healthcare facilities in rural regions as well. The state has 6,419 community health officers (CHOs) at the sub-health centre level who will use teleconsultation to connect patients in villages with specialists in district hospitals or community health centres. Meanwhile, the state government plans to start providing free OPD and IPD services in metropolitan areas on May 1 as part of the Mukhya Mantri Nishulk Nirogi Rajasthan Yojana. Teleconsultation between doctors will be possible, allowing them to discuss a patient’s diagnosis and treatment. “Orders have been issued in this regard,” a senior health department official said. “It will help patients get consultations of specialist doctors in their villages.” From 11 a.m. to 2 p.m., doctors from SMS Medical College’s super-specialty departments such as cardiology, neurology, medico-oncology, nephrology, and endocrinology will give teleconsultation. The number of specialised doctors will be raised if the volume of calls for teleconsultation increases in the following days. Physicians, gynaecologists, paediatricians, psychiatrists, dermatologists, and ENT specialists will be available for teleconsultation at hospitals affiliated with government medical colleges. In this approach, all CHOs stationed at the sub-health centres that will be converted into health wellness centres will act as ‘spokes,’ in this model, with each of the 6,419 CHOs providing teleconsultation to 10 patients. Source: TNN

Teleconsultation will help rural areas boost their healthcare Read More »

Ayushman Bharat Block Health Melas conduct around 6 lakh diabetes screenings in a week

In a week, 6.75 lakh hypertension screenings, 6.11 lakh diabetes screenings, 2.05 lakh cataract screenings, and over 1.76 lakh teleconsultations were conducted at Ayushman Bharat block-level health melas, according to the Union Health Ministry. In a week, more than 27.31 lakh people visited 3,204 block health melas in 33 states and UTs, according to the report. Over 3.66 lakh ABHA (Ayushman Bharat Health Account) IDs were issued across India, with the highest number of 56,321 in Maharashtra, while over 1.17 lakh Pradhan Mantri Jan Arogya Yojna (PMJAY) golden cards were created, predominantly in Karnataka (22,091). According to the government, 1,009 Block Health Melas held blood donation camps and 519 had organ donation registration. From April 16 to 22, the Ministry of Health, in conjunction with states and union territories, will commemorate the fourth anniversary of Ayushman Bharat Health and Wellness Centres (AB-HWCs) as part of the Azadi ka Amrit Mahotsav. The Block Health Melas began on April 18 across 33 Indian states and union territories. These health melas are attracting thousands of individuals to get quality healthcare, as well as necessary drugs and diagnostic services, according to the statement. They provide as a platform for health education, wellness lifestyle information, and other healthcare services aimed at early disease diagnosis and treatment. The melas will run until the end of April, according to the statement. The Union Health Minister, Health Ministers of States and UTs, MPs, MLAs, senior officials of the Union Health Ministry, Principal Health Secretaries/Health Secretaries of States/UTs, senior officials of the state Health department, representatives, and local dignitaries are also visiting AB-HWCs to raise public awareness about the importance of AB-HWCs in providing affordable and accessible healthcare. Source: PTI

Ayushman Bharat Block Health Melas conduct around 6 lakh diabetes screenings in a week Read More »

AYUSH doctors to be trained in primary trauma care

For the first time in the country, AYUSH doctors will receive training in primary trauma treatment. The Union AYUSH ministry and the city-based NGO Lifeline Foundation signed an MoU in this regard. The programme, which is being carried out in collaboration with the AYUSH ministry, aims to train 4,000 doctors across the country. Gujarat, Rajasthan, and Madhya Pradesh will be the first states to implement the programme. In Gujarat, there will be 2,000 AYUSH doctors. The project’s Memorandum of Understanding was signed in Gandhinagar on the first day of the Global AYUSH Investment and Innovation Summit 2022. The training would be delivered in modules approved by Rashtriya Ayurved Vidyapeeth, the ministry’s central office in New Delhi. Dr. Subroto Das, the founder trustee of Lifeline Foundation and a Padma Shri awardee, said the effort was part of Prime Minister Narendra Modi’s vision to mainstream AYUSH doctors and address unnecessary deaths from all sorts of trauma. He went on to say that this will be the first-of-its-kind upskilling aimed at lowering trauma-related mortality by incorporating training for AYUSH doctors. According to Das, India has more than 7.7 lakh AYUSH doctors. “Already pilot projects to train 500 doctors have been completed in Vadodara, Vapi, Godhra, Lunawada, Modasa and rural areas of Saurashtra. Rural areas have been targeted because they are mostly bereft of trauma care facilities and are unable to address the Golden Hour. This is where AYUSH doctors can make a difference since they have a good presence and acceptability in the rural communities,” said Das. Airway management, haemorrhage control and suturing, IV access and hydration management, cervical spine stabilisation, CPR, and cardiac arrest are among the low-cost procedures covered in the 8-hour session. Trauma surgeons, orthopaedic surgeons, general surgeons, emergency physicians, and ICU physicians will give the training. The objective is to do impact studies on a regular basis, change the modules as needed, scale it nationally with the AYUSH ministry’s help, and then institutionalise these skill developments as part of training. Lifeline Foundation established India’s first CPR project in addition to its much-lauded highway rescue effort. The Vadodara Municipal Corporation became the country’s first civic body to be fully trained in high-quality first aid and CPR. Source: Economic Times  

AYUSH doctors to be trained in primary trauma care Read More »

DDMA meeting on Wednesday, likely to discuss compulsory use of masks

In light of the rising number of infections in recent days, a major meeting of the DDMA on Wednesday is expected to discuss mandatory usage of face masks and a hybrid form of offline and online instruction for schoolchildren, according to official sources. As per the meeting notification, the COVID situation in the national capital would be reviewed at a meeting of the Delhi Disaster Management Authority (DDMA) chaired by Lt Governor Anil Baijal. After the DDMA removed a fine of Rs 500 earlier this month, the use of masks by persons in Delhi has “significantly” decreased. Given the increased number of infections, this is not a desirable situation, according to a senior government official. The mandatory mask use in Delhi is most likely to be discussed during the meeting, with reimposing fines for its strict implementation,” said the officer, citing the UP-government’s decision today to make it mandatory for residents of six NCR cities in the state. Due to an increase in Covid cases in some neighbouring states, the Uttar Pradesh government made it mandatory for people to wear a face mask in public areas in the capital Lucknow and six NCR districts, including Noida and Ghaziabad, on Monday, an official said. In light of concerns of children becoming infected, the DDMA conference could also discuss giving schools the choice of using both offline and online teaching methods, according to sources. Following a surge in Covid cases, schools throughout Delhi-NCR have jumped into action, implementing a variety of measures, including periodic sanitization, to keep the virus at bay and avert campus closure. At a time when scores of students and workers at institutes across the NCR cities have been diagnosed with COVID-19, the Haryana education department has instructed schools in the state not to make it essential for pupils to attend physical classes. In the city, the number of pupils testing positive for drugs is on the rise, causing anxiety among parents. Wherever any student or teacher is confirmed infected, the Delhi government has directed school officials to close specific wings or classes. Though the number of COVID-19 cases in the national capital is increasing, Delhi Health Minister Satyendar Jain remarked earlier in the day that the situation is not serious because the incidence of hospitalisation is low. He stated that the government is monitoring the issue. He also emphasised the importance of wearing face masks, despite the fact that the penalties for not doing so had been withdrawn. “In Delhi, the number of positive cases has been increasing. However, we have completed 100% immunisation, and the (corona) virus has already infected a big number of individuals. In addition, there aren’t many hospitalizations. As a result, the situation is not frightening. We’re keeping a close eye on everything” Jain said in a briefing. When asked about the rise in COVID-19 cases among children, the minister said the Delhi government has already issued an advisory instructing schools to halt specific classes for a few days if any student or teacher tests positive for the coronavirus. Source: PTI

DDMA meeting on Wednesday, likely to discuss compulsory use of masks Read More »

DCGI claims India on course to become global drugs hub

Dr. VG Somani, Drug Controller General of India (DCGI), claimed that India is on track to become a “global hub for medicines,” claiming that there has been a fourfold increase in applications for investigational new drugs in the country. “We are getting the applications of the investigational new drugs. Earlier, there used to be hardly 5-10 applications. At present, there are 23 applications in the pipeline for the investigational new drug and this is a great achievement of our country,” Somani said, speaking at the Indian Drug Manufacturers’ Association (IDMA) Annual Conclave. He believes that “Made in India” drugs will make a difference and spread throughout the world in the coming years. The DCGI official also explained how drug controllers work while making vaccine and drug decisions. “We have been in regular contact with the WHO and all global regulators via the ICMR, ICH platform, and so on. There are various platforms for vaccine and drug approval, including trials. That is exactly what we did with remdesivir.  There is no single decision-making platform,” he added. He went on to say that India has been designated as a “world pharmacy,” and that “we want to become the well-managed pharmacy of the entire world so that our potential can be recognised.” Source: ANI

DCGI claims India on course to become global drugs hub Read More »

Country setting new benchmarks in field of health: PM Modi

Prime Minister Narendra Modi praised people’s determination in the fight against Covid on Tuesday, saying that whether it’s the world’s largest free vaccination campaign or medical infrastructure development, India is setting new health benchmarks. Modi posted a graphic on Twitter highlighting the accomplishments of India’s Covid vaccination campaign, which has resulted in over 185 crore cumulative doses administered in the country. “The resolve shown by 130 crore people in the country in the fight against coronavirus signifies the strength of New India,” Modi said in a tweet in Hindi. “Whether it is the world’s largest free vaccination campaign with indigenous vaccines or the development of medical infrastructure, the country is setting new benchmarks in the field of health,” PM said. Source: PTI

Country setting new benchmarks in field of health: PM Modi Read More »